US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist

44.870
+0.250+0.56%

Close Sep 9 16:00 ET

45.000
+0.130+0.29%

Post 20:02 ET

3.82BMarket Cap-14021P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 32.861M	--
--	2024/Q3	-- / 7.566M	--
--	2024/Q2	517.000K / 13.613M	--
--	2024/Q1	504.000K / 26.494M	--
--	2023/Q4	201.206M / 123.085M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 32.861M--

--2024/Q3-- / 7.566M--

--2024/Q2517.000K / 13.613M--

--2024/Q1504.000K / 26.494M--

--2023/Q4201.206M / 123.085M--

Unlock Free Earnings Estimates

Open Account

CRISPR Therapeutics Earnings Reports

CRISPR Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 5 16:13 ET

CRISPR Therapeutics | 10-Q: Q1 2024 Earnings Report

May 8 16:29 ET

CRISPR Therapeutics | 10-K: FY2023 Annual Report

Feb 21 07:55 ET

CRISPR Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 6, 2023 16:42 ET

Analyst Rating

Updated: Aug 31, 2024

Buy

Buy
55.56%
Hold
33.33%
Sell
11.11%

Price Target

No Data

Overall